West Pharmaceutical Services announced that they will form a new facility in Ireland for the production of insulin injector cartridge packaging components.
West Pharmaceutical Services announced on Oct. 2, 2014 that they plan to expand their manufacturing operations in Waterford, Ireland. West, which is internationally headquartered in Exton, Pennsylvania, produces standard-setting systems and device components for parenterally administered medicines. The new facility will produce packaging components for a variety of items, including insulin injector cartridges.
“With diabetes emerging as one of the fastest growing diseases globally, our pharmaceutical customers are expanding their production lines for injectable insulin. To meet this growing demand, we are announcing an expansion today that will help us address this need and continue to serve this critical patient population,” said Donald E. Morel, Jr., West’s chairman and CEO.
The construction, which will take place on a 44-acre site, is expected to begin in early 2015.
